Susceptibility to Pathological Gambling | Clinical Trial

Key information

Conditions

Pathological Gambling Behavior Disruptive, Impulse Control, and Conduct Disorders Gambling Mental Disorders Risk-Taking

Age range

18 year–29 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Chicago

Chicago, Illinois, 60637, United States

About this study

This study will track up to 600 young adults (ages 18 to 29) for a two-year period, collecting variables such as gambling behavior, drug and alcohol use, psychiatry and medical history, family history, impulsivity, quality of life, self-esteem, and cognition. For some individuals who meet criteria as being impulsive, they will be randomized to receive an intervention to help reduce their impulsivity.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Ability to understand the procedures and provide written consent
Gambled at least 5 times in the past year
Between the ages of 18 and 29 at intake

Exclusion criteria

Inability to understand the procedures and provide written consent

Treatment and study plan

Mindfulness

Behavioral

Subjects receive mindfulness training

Other names: Training

Cognition

Behavioral

Subject receive cognitive training

Other names: Training

Primary outcomes

Structured Clinical Interview for Pathological Gambling (SCI-PG)

Time frame: Up to 3 years

The SCI-PG is a validated and reliable scale assessing the presence of DSM-IV criteria for pathological gambling. The number of criteria met for PG is added for a total score and those meeting 5 or more criteria have DSM-IV pathological gambling.

Subjects are expected to be followed for the duration of the 3 year study.

Diagnostic criteria for pathological gambling every 3 months for the length of the study

Sponsors and collaborators

Lead sponsor

University of Chicago

Other

Registry information

Important dates

Study start: 2008
Primary completion: 2024
Study completion: 2024
First posted: Feb 8, 2012
Registry last updated: Aug 1, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed